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showing the highest protection factor of 55.1%, and eliminating 39% of radiation induced cell death in cells PNT2 (p<0.001). The
results point to a signiﬁcant genoprotective capacity of the different substances assayed with a maximum radiation protection
factor of 60% and a dose-reduction factor of 4.9 for CAR. Cell survival obtained with CAR administered with up to 10Gy showed
a Protection Factor of 100%, eliminating 30.8% of radioinduced cell death.
Conclusions. In the normal epithelial cells CAR acts as an antioxidant which can eliminate the excess free radicals induced by IR
in conjunction with the intracellular redox defensive system. Acknowledgments This report was supported by a grant from the
Seneca Foundation and other grant from Programme CENIT denominated SENIFOOD.
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Background. Several groups have studied the association between TGF-b1 single nucleotide polymorphisms (SNPs) and the risk
of developing radiation-induced lung toxicity (RILT) in patients with lung cancer.
Aim. The objective of this study was to carefully assess the potential reasons for the contradictory results reported about this
topic.
Methods. A search was based on PubMed electronic database. The following terms and limits were explored and used for
the database search: TGF, lung cancer, polymorphisms, and radiation. We then assessed potential confusing factors includ-
ing the ethnicity, endpoint used, and the analysis methodology that may explain the difference in ﬁndings among the
reports.
Results. Three studies (U.S., European, and Chinese) were found using the terms and limits mentioned above. The Chinese and
European studies could not validate the previously association found in a US cohort between the CT/CC genotypes of SNP
rs1800470 and a lower risk for treatment related pneumonitis. Several potential reasons that may explain this divergence were
found. First, there were differences in the distribution of allele frequencies and genotypes among the three analyzed cohorts
(P<0.001). Second, in the European study lung toxicity was scored using the CTC v3.0 for dyspnea. In contrast, the U.S. and
Chinese studies assessed the development of RILT including radiologic ﬁndings for changes in the lung. Finally, whereas the U.S.
and Chinese studies included the event time into account in their analyses, the European study did not consider it in the RILT
calculation.
Conclusions. Our ﬁndings suggest that the frequency patterns of polymorphisms in TGF-b1 gene vary greatly among different
ethnic groups. In addition, it is expected that the results would be different if the studies being compared are studying different
endpoints and using different statistical analysis methodology. A prospective validation is needed to elucidate the association
between RILT and TGF SNPs.
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Introduction. A growing number of studies have shown that a small proportion of tumor stem cells (TSC) exists in the tumor
cell population. The TSC has a powerful capacity for self-renewal and tumor initiation. They are resistant to chemotherapy and
radiotherapy. Moreover stem cells of normal tissues (NTSC) are important in the repair and recovery after damage induced by
radiation.
Objective. To ﬁnd it’s radiation response proﬁle we performed irradiation experiments on mesenchymal cells derived from human
adipose tissue characterized by international standards.
Methods. We compared two different irradiation sources of linear energy transfer (LET): 6MV photons from linear accelerator and
radiation sources I125. Was studied a dose range of 0.5–2Gy. Original design was conducted in which, using a limited number of
sources and cells can be efﬁciently establish a curve of dose response and mortality analyze and cell proliferation.
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Results. It was determined that these cells are sensitive to radiation damage in a dose dependent manner and in an order of
magnitude that respects the theoretical prediction of biological efﬁcacy against both types of radiation employed.
Conclusion. This study establishes and characterizes the basics of a model of the original irradiation on a cell type not extensively
studied in terms of their response to radiation or clinical signiﬁcance in the toxicity and radiation repair: human mesenchymal
stemcells. Themodel developedanddescribed is the basis for increasing knowledgeof radiobiology of stemcells, and is applicable
to other cell types.
http://dx.doi.org/10.1016/j.rpor.2013.03.637
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Introduction. Ibandronate (IBD) is a bisphosphonate used in hypercalcaemia-related cancers, in complications from bone metas-
tasis and in postmenopausal osteoporosis and has often been associated with osteoradionecrosis, especially amongst cancer
patients receiving radiation to the head and neck area.
Objectives. To determine the cytotoxicity of IBD in combination with ionizing radiation (IR) treatment by evaluating its genotoxic
and cytotoxic effects in non-tumoral cells.
Methods. The genotoxic effect of IBD was studied by means of the micronucleus test in cytokinesis-blocked cells of human
lymphocytes irradiated to 2Gy irradiation, while the cytotoxic effect was studied by a cell viability test (MTT) in PNT2 cells before
and after exposure to different X-ray doses (0–20Gy). The results of these treatments were compared with those elicited by
recommended human dose of Zoledronic acid (Z5%).
Results. At the concentrations of IBD recommended for humans, we did not determine any genotoxic, cytotoxic or synergistic
effect with ionizing radiation. With higher concentrations we established a cytotoxic effect on PNT2 cells (p<0.001); the combined
treatment with IR had a more pronounced effect than individual treatments (p<0.001), increasing the enhancement ratio (1.3)
and sensitization factor (23.6%). With the concentration of Z(5%), the combined treatment had a more pronounced effect than
individual treatments(p<0.001). The effect was synergic (CI < 1), increasing the Z enhancement ratio (2.6) and sensitization factor
(56%). For the genotoxic effect, only the administration of Z after irradiation (IR+Z) increased chromosome damage (p<0.001)
and the sensitization factor (35.7%).
Conclusion. The recommended clinical concentrations of IBD did not induce cytotoxic or genotoxic damage in non-tumor cells
neither did it show an additive effect with the IR. Only at very high concentrations is an increase in cytotoxicity with signiﬁcant
radiosensitizing noted similar to that produced by Z5%.
Acknowledgments. This report was supported by a grant from the Seneca Foundation and other grant from Programme CENIT
denominated SENIFOOD.
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Purpose. To determine the potentially paradoxical effect of rosmarinic acid (RA), typically being radioprotective when applied to
non-tumour cells yet conversely displaying a sensitizing action when applied to metastatic (B16F10) melanoma cells.
Methods. To analyze the radioprotective effects of the substances studied on cell viability and survival, we used the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay for 24 or 48h in B16F10 (melanoma) cell lines when they
were administered before exposure to different X-ray doses (4, 6, 8, 10 and 0Gy). An analysis of variance (ANOVA) of repeated
means was used to compare the percentages of surviving cells. This was complemented by least signiﬁcant deference analyses
to contrast pairs and means. To determine the Protection Factor (PF) the formula described by Sarma and Kesavan (1993) was
modiﬁed for the analysis of growth inhibition.
Results. RA shows a signiﬁcant genoprotective capacity (p<0.001) against X-rays with a protection factor of 58%, and a dose
reduction factor of 7.2. Cell survival obtained with RA after exposure to 10Gy of X-rays showed a protection factor of 47.5%, thus
eliminating 29.1% of radiation-induced cell death in normal prostate epithelial cells (PNT2) (p<0.001). However, in the metastatic
B16F10 melanoma cells, RA acted not as a radioprotector but as a sensitizing agent, increasing cellular death by 42% (p<0.001)
and producing an enhancement ratio of 2.36.
